Juliet Emamaullee MD, PhD
Assistant Professor of Clinical Surgery, USC Keck School of Medicine; Attending Transplant Surgeon, Keck Hospital of USC and Children's Hospital-Los Angeles; Associate Chief, Division of Clinical Research, USC Department of Surgery, Los Angeles, CaliforniaDr. Juliet Emamaullee is an Assistant Professor of Clinical Surgery at the USC Keck School of Medicine and an attending transplant surgeon at Keck Hospital of USC and Children's Hospital-Los Angeles. She is also the Associate Chief, Division of Clinical Research, USC Department of Surgery, where she helps oversee >70 clinical trials. She is a surgeon-scientist with an NIH-funded translational immunology lab, exploring immunological phenotypes associated with liver transplant recipients. Dr. Emamaullee’s other research interests include living donor liver transplantation, disparities in access to liver transplant, Fontan-associated liver disease, and tolerance strategies to improve allograft survival.
Dr. Emamaullee received her B.Sc. in Chemistry in 2000 from the University of Alabama and then completed her Ph.D. in Immunology (2005) and M.D. (2010) at the University of Alberta. Dr. Emamaullee completed her residency in General Surgery at Emory University in 2015. She returned to the University of Alberta for fellowship training in transplant and hepatobiliary surgery and then joined the faculty of USC upon completion, in the Fall of 2017.
Dr. Emamaullee holds leadership roles in several surgical societies including the American College of Surgeons, American Society of Transplant Surgeons, American Society of Transplantation, and Association for Academic Surgery. She serves as Chair of the North American Living Liver Donation Innovation Group and is on the Steering Committee for the UNOS Liver Paired Exchange Pilot Program. She has >90 peer-reviewed publications, has received >50 awards, and has >$2 million in extramural funding including a National Cancer Institute K08 Award.
Disclosures
Dr. Emamaullee reports the following:
- Data Monitoring Committee, iSPY COVID Trial
- Medical Monitor, iVAED Study